Chinese herbal medicine boosted muscle mass and grip strength in sarcopenia trials

Sarcopenia, the age-related loss of muscle mass, strength and function, is a growing public health problem as populations get older. The standard responses, drug therapy, exercise and nutritional intervention, help but leave many people short of satisfactory results, which is why alternatives keep being explored. Chinese herbal medicine is widely practised and increasingly proposed for sarcopenia, yet its effectiveness had not been comprehensively pooled across randomised trials. This review set out to test whether the herbal approach, alone or combined with conventional treatment, actually improves the measures that matter: muscle mass, strength and physical function.

The reviewers searched a broad set of international and Chinese-language databases from their inception to December 2022, with no language restrictions, for randomised controlled trials of Chinese herbal medicine in sarcopenia. Of 277 studies identified, 17 met the inclusion criteria, covering 1,440 participants in total. Outcomes were pooled using standard statistical methods and spanned muscle mass, grip strength, knee extension strength, 6-metre walking speed, a physical performance battery and quality of life. The team also ran formal checks for publication bias, including a funnel plot and a statistical test.

Chinese herbal medicine improved muscle mass and grip strength compared with control conditions, and 6-metre walking speed also improved meaningfully. A measure of knee extension strength moved in the right direction but did not reach statistical significance, and a quality of life score showed no clear effect either. A pooled measure of overall treatment response also favoured the herbal interventions. The important sour note: both the funnel plot and the formal test indicated publication bias, meaning trials with unimpressive results may be missing from the record, which would make the pooled benefits look larger than they really are.

These results position Chinese herbal medicine as a possible addition to, rather than a replacement for, conventional sarcopenia care built on exercise, nutrition and medication. The pooled gains in muscle mass, strength and walking speed are encouraging, but the evidence base is small at 17 trials, the formulas tested were varied, and the detected publication bias weakens confidence in the size of every effect. The authors themselves call for further high-quality studies before firm conclusions are drawn. Until rigorous trials with consistent formulas appear, this sits in the promising but unproven column.

If you have seen herbal products marketed for ageing muscle, this review explains why the claim is not baseless: pooled trial evidence does show improvements in muscle mass, grip strength and walking speed. It also explains why scepticism remains warranted, since the same analysis found signs that trials with disappointing results may never have been published. Because the studies tested many different formulas, no single product can borrow this evidence for itself. For now, this is knowledge about a developing research area rather than a reason to change how you approach muscle loss.